|Values are valid only on day of printing.|
Detection of HIV-1 and/or HIV-2 antibodies in cadaveric or hemolyzed serum specimens from symptomatic patients with or without risk factors for HIV infection. This assay is FDA-approved for testing cadaveric or hemolyzed blood specimens.
|Test ID||Reporting Name||Available Separately||Always Performed|
|HIVDI||HIV-1/-2 Ab Differentiation, S||Yes||No|
|HV1WB||HIV-1 Ab Confirm by Western Blot, S||Yes||No|
|HIV2L||HIV-2 Ab Confirmation, S||Yes||No|
This test begins with HIV-1/-2 antibody EIA. If HIV-1/-2 antibody EIA is reactive, then HIV-1/-2 antibody differentiation is performed at an additional charge. HIV-1 and HIV-2 antibody differentiation test begins with the Bio-Rad Multispot HIV-1/HIV-2 Rapid Test, with the following reflex testing. Specimens with indeterminate HIV-1 antibody but negative HIV-2 antibody results then HIV-1 antibody confirmation by Western blot is performed at an additional charge. Specimens with reactive or unreadable results for both HIV-1 and HIV-2 antibodies then HIV-1 antibody confirmation by Western blot and HIV-2 antibody confirmation are performed at additional charges. Specimens with negative HIV-1 antibody but reactive HIV-2 antibody results then HIV-2 antibody confirmation is performed at an additional charge.
The following algorithms are available in Special Instructions:
-HIV Testing Algorithm (Fourth Generation Screening Assay) Including Follow-up of Reactive HIV Rapid Serologic Test Results
Enzyme Immunoassay (EIA)-Screening Procedure